Propionic Acid in Multiple Sclerosis

Clinical trial NCT06402487 · COMPLETED

Trial details

NCT number: NCT06402487
Sponsor: Salzburger Landeskliniken
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2024-05-01
Primary completion: 2024-09-15
Enrollment: 101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.